Diligent is the pioneer in modern governance. We empower leaders to turn governance into a competitive advantage through unparalleled insight and highly secure, integrated SaaS applications, helping organizations thrive and endure in today’s complex, global landscape.
The largest global network of corporate directors and executives, Diligent is relied on by more than 16,000 organizations and 650,000 leaders in over 90 countries.
With award-winning customer service, Diligent serves more than 50% of the Fortune 1000, 70% of the FTSE 100, and 65% of the ASX.
Our passionate, smart, and creative group of more than 1,000 employees support customers around the globe from offices inNew York, London, Washington, DC, Amsterdam, Sydney, Christchurch, and Charlotte, NC.
The Diligent Production Operations team is looking for a Site Reliability Engineering Manager to lead the DevOps and Release Engineering teams in Christchurch New Zealand.
The SRE Manager will build collaboration between the Development, Product, Security, and Engineering teams to help expand and improve Diligent’s SaaS applications.
Diligent’s global presence reaches across 10 regional datacenters, all of which utilizes Diligent’s own private cloud. This position is fast paced and will require an experience leader.
The ideal candidate will be a sharp individual with a strong work ethic and great communication skills.
Required Experience / Skills :
FSLA Status : Exempt
Diligent offers acompetitive compensation and benefits package, including health, vision, dental, 401k with a strong match, health club reimbursement and much more.
We are a drug free workplace, and an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religious creed, sex, national origin, ancestry, citizenship status, pregnancy, childbirth, physical disability, mental disability, age, military status, protected veteran status, marital status, registered domestic partner or civil union status, gender (including sex stereotyping and gender identity or expression), medical condition (including, but not limited to, cancer related or HIV / AIDS related), genetic information, or sexual orientation in accordance with applicable federal, state and local laws.